• Colorectal cancer: $281 million
• Crohn’s disease: $61 million
• Digestive diseases (general): $1.58 billion
• Digestive diseases (gallbladder): $10 million
• Digestive diseases (peptic ulcer): $19 million
More Articles on Gastroenterology:
ASCA, U.S. Rep. Charlie Dent Partner to Promote Colorectal Cancer Screening
7 Gastroenterologists on Benchmarking & Colonoscopy Quality (Part 2)
Covenant Endoscopy Center to Offer Free Colonoscopy Screenings
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
